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DObjective: The primary objective was to assess the feasibility and accuracy of intraoperative sentinel lymph node
mapping by using a video-assisted thoracoscopic indocyanine green fluorescence imaging system in patients with
clinical stage I non–small-cell lung cancer.
Methods: Thirty-one patients who underwent operation between January 2009 and September 2009 were inves-
tigated for sentinel node biopsy. Indocyanine green fluorescence imaging was applied by an infrared light charge-
coupled device, and sentinel nodes were identified intraoperatively and dissected. Histologic examination by
hematoxylin-eosin staining was used to evaluate metastases.
Results: Sentinel lymph nodes were identified by segmentectomy in 11 of 14 patients (78.5%) and by lobectomy
in 14 of 17 patients (82.4%). The total identification rate was 80.7% (25/31 patients), the false-negative rate was
0% (0/24 patients), and the overall accuracy rate was 80.7% (25/31 patients).
Conclusion: Video-assisted thoracoscopic indocyanine green fluorescence image-guided surgery is feasible for
sentinel node biopsy and may be a powerful tool to eliminate unnecessary lymph node dissection in patients with
lung cancer. (J Thorac Cardiovasc Surg 2011;141:141-4)Sentinel node navigation surgery has been the standard treat-
ment for malignant melanoma1 and breast cancer2 surgery.
The sentinel lymph node is defined as the first lymph node
within the lymphatic basin from the tumor. However, the
application of sentinel node navigation surgery in non–
small-cell lung cancer (NSCLC) is not popular because of
the difficulty of sentinel node identification and the low in-
cidence of complications after systemic lymph node dissec-
tion.3 As previously reported, sentinel lymph node biopsy
using isosulfan blue dye failed because of a lower detection
rate caused by anthracotic black lymph nodes.4 Liptay and
colleagues5 reported radiolabeled tracer methods that used
technetium 99mTc sulfur colloid. Their results were satis-
factory and showed an 82% identification rate and a 95%
accuracy rate. The technique of radiolabeled tracer injection
during the operation, in vivo and ex vivo mapping as
described previously,6 was reported in the results of the Can-
cer and Leukemia Group B 140203 phase II trial.7 However,
the complexity of radiolabeled tracer injection may lead to
low use of this technique.3
Because the dye including indocyanine green (ICG) is
not visible in anthracotic lymph nodes, ICG was note Department of Surgery II, Faculty of Medicine, Oita University, Yufu, Oita,
.
ures: Authors have nothing to disclose with regard to commercial support.
d for publication Nov 10, 2009; revisions received Dec 20, 2009; accepted for
cation Jan 18, 2010; available ahead of print April 15, 2010.
for reprints: Shin-ichi Yamashita, MD, Department of Surgery II, Faculty of
cine, Oita University, 1-1 Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan
ail: yamashi1@med.oita-u.ac.jp).
23/$36.00
ht  2011 by The American Association for Thoracic Surgery
016/j.jtcvs.2010.01.028
The Journal of Thoracic and Caused for sentinel node biopsy of lung cancer. However, be-
cause ICG is known to absorb infrared rays in vivo binding
with serum protein, the ICG fluorescence imaging system
was developed and applied to gastric,8 breast,9 and skin10
surgery, but not lung surgery. This report shows the new
technique of sentinel node navigation surgery by video-
assisted thoracoscopic ICG fluorescence imaging in
NSCLC.MATERIALS AND METHODS
Eligibility
Patients aged more than 20 years with clinically diagnosed stage I lung
cancers were considered for enrollment in this study. Patients with prior ra-
diotherapy or chemotherapy of lung cancer were excluded. This feasibility
study was started in January 2009. The study was approved by the institu-
tional review board of Oita University, and all patients completed informed
consent forms. The samples were histologically diagnosed for primary lung
cancer by hematoxylin & eosin staining.
Objective
The primary objective of this study was to assess the feasibility and ac-
curacy of intraoperative sentinel lymph node mapping in patients with clin-
ical stage I NSCLC at Oita University. The sentinel node accuracy rate was
based on the number of patients with sentinel nodes positive for metastatic
disease and on the number of patients with sentinel nodes negative for
nonmetastatic disease and no metastases in any other hilar or mediastinal
lymph nodes.
Technique
After initial thoracoscopic exploration, ICG fluorescence imaging was
applied by an infrared light charge-coupled device (CCD) (Olympus, To-
kyo, Japan) equipped to filter out light with 800 nm wavelength. Light
through an exciting filter (690–790 nm) leads to image formation, and it
was converted to a digital image under monitor view. Two millilitersrdiovascular Surgery c Volume 141, Number 1 141
FIGURE 1. Video-assisted thoracoscopic ICG fluorescence imaging sys-
tem shows the sentinel nodes at the interlobar nodes (11i) in the primary
lung adenocarcinoma of the right lower lobe. A, Thoracoscope with normal
light does not show the green dye staining because of anthracosis. B, Fluo-
Abbreviations and Acronyms
CCD ¼ charge-coupled device
ICG ¼ indocyanine green
NSCLC ¼ non–small-cell lung cancer
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D(5 mg/mL) of ICG were injected around the tumor using 25-gauge needles,
and sentinel nodes were detected 10 minutes after injection. During the
time allowed for migration of the ICG through the lymphatics, care was
taken to avoid leakage or intrathoracic spreading because these effects
make the true sentinel nodes invisible. Therefore, we immediately closed
the injection site by using an EndoClip (Covidien, Mansfield, Mass) or En-
doloop (Medcompare, South San Francisco, Calif) after injection. Sentinel
node sampling was followed by lobar or segmental resection of the lung.
Green fluorescent nodes were dissected as sentinel nodes (Figure 1). All
systemic lymph node dissection, which includes a full hilar and mediasti-
nal node dissection, was followed by lung cancer resection for feasibility.
In the case of segments in the upper lobe, intersegmental, interlobar, hilar,
and upper mediastinal nodes were dissected. In the lower lobe, subcarinal
and lower mediastinal node dissection was added to the lymphadenectomy
described above.
Pathologic Examination
After sentinel node dissection, sentinel nodes were examined by standard
histology with hematoxylin-eosin by conventional methods. One-half of the
sentinel nodes were fixed in formalin and embedded in paraffin for histo-
logic examination.
rescence imaging system visualizes the lymph nodes.
TABLE 1. Patient characteristics
Characteristics
Age y
Median (range) 63 (54–83)
Gender
Male (%) 18 (58)
Female (%) 13 (42)
Histologic type
Ad (%) 13 (42)
Sq (%) 2 (7)
BAC (%) 15 (48)
Others (%) 1 (3)
p-Stage
IA (%) 27 (87)
IB (%) 3 (10)
IIIA (%) 1 (3)
Operation
Segmentectomy (%) 14 (45)
Lobectomy (%) 17 (55)
BAC, Bronchioloalveolar carcinoma; Sq, squamous cell carcinoma; Ad, adenocarci-
noma.RESULTS
Thirty-one patients who underwent operation at Oita Uni-
versity Hospital (Oita, Japan) between January 2009 and
September 2009 were eligible for this study. The character-
istics of the patients are shown in Table 1. Intraoperative
ICG fluorescence imaging was applied by an infrared light
CCD system. The sentinel nodes were detected 10 minutes
after injection of 2 mL (5 mg/mL) of ICG around the tumor.
Sentinel node sampling was followed by lobar (17 cases) or
segmental (14 cases) resection of the lung. Green fluorescent
nodes were dissected as sentinel nodes (Figure 1) and exam-
ined by hematoxylin-eosin staining. All systemic lymph
node dissection was followed by lung cancer resection for
feasibility. Sentinel lymph nodes were identified by segmen-
tectomy in 11 of 14 patients (78.5%) and by lobectomy in 14
of 17 patients (82.4%) (Table 2). The total identification rate
was 80.7% (25/31). The causes of failure are shown in Table
2. The average number of sentinel nodes was 1.4 by segmen-
tectomy and 1.3 by lobectomy. The only case in the left up-
per lobe showed sentinel node positivity by conventional
methods (Table 2). One case of pathologic N2 disease was
confirmed by positive sentinel nodes (number 10) and medi-
astinal nodes (number 5). The other cases showed no metas-
tases in the sentinel nodes, and all dissected nodes were
staged as N0 by examination of pathologic specimens. The
false-negative rate was 0% (0/24 patients), and the overall
accuracy rate was 80.7% (25/31 patients). Of the 31 patients,142 The Journal of Thoracic and Cardiovascular Surg24 had pathologically identified negative sentinel lymph
nodes.
DISCUSSION
Sentinel node biopsy is the standard technique in surgery
for melanoma1 and breast cancer.2 The sentinel node is theery c January 2011
TABLE 2. Patient data
No. Age y Gender Histology Location Operation pT pN SLN Metastasis Cause of failure
1 75 F BAC LtS1þ2 seg 1 0 10, 11 negative
2 63 F BAC LtS6 seg 1 0 11, 13 negative
3 71 M BAC LtS1þ2 seg 1 0 ND adhesion
4 70 F BAC RtS3 seg 1 0 ND adhesion
5 62 F BAC LtS3 seg 1 0 10, 11 negative
6 59 M Ad, BAC RtS6 seg 2 0 12 negative
7 60 M Ad LtS10 seg 1 0 10 negative
8 56 M BAC RtS1 seg 1 0 13 negative
9 71 M Ad LtS1þ2 seg 1 0 10, 12 negative
10 71 M BAC LtS1þ2 seg 1 0 ND leakage
11 54 F BAC RtS3 seg 1 0 10 negative
12 79 F La LtS8 seg 1 0 12 negative
13 65 M BAC LtS3 seg 1 0 10 negative
14 73 F Ad LtS1þ2 seg 1 0 10 negative
15 62 F BAC RtS4 lob 1 0 10, 11s negative
16 80 M Sq RtS2 lob 1 0 11 negative
17 64 M Sq LtS1þ2 lob 1 0 4, 11 negative
18 57 F BAC LtS3 lob 2 2 10 positive
19 63 M Ad RtS6 lob 2 0 11i negative
20 74 F BAC RtS3 lob 1 0 3 negative
21 83 F Ad RtS3 lob 2 0 4, 10 negative
22 63 M Ad LtS9 lob 1 0 ND incomplete fissure
23 61 F BAC RtS9 lob 1 0 11s negative
24 60 M Ad RtS1 lob 1 0 ND leakage
25 62 M Ad LtS6 lob 1 0 10 negative
26 55 F BAC RtS1 lob 1 0 11s negative
27 61 M BAC RtS4 lob 1 0 11i negative
28 70 M Ad RtS8 lob 1 0 10, 11i negative
29 73 M Ad RtS2 lob 1 0 10 negative
30 63 M Ad RtS2 lob 1 0 ND leakage
31 70 F Ad RtS2 lob 1 0 11s negative
SLN, Sentinel lymph node; BAC, bronchioloalveolar carcinoma, Ad, adenocarcinoma, Sq, squamous cell carcinoma; La, large cell carcinoma, seg, segmentectomy; lob, lobectomy;
ND, not detected; LtS, left; RtS, right.
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Dfirst lymph node drained from the lymphatic basin and repre-
sents the state of the remaining regional nodes. Sentinel node
biopsy avoids unnecessary dissection of non-metastatic nodes
and limits morbidity. Another benefit is the possibility of
more focused pathologic or molecular evaluation (eg, serial
sections, immunohistochemistry, reverse transcriptase-
polymerase chain reaction) for staging.The lattermay be a pri-
mary benefit in lung cancer surgery.
This study focused on the development of a new tech-
nique of sentinel lymph node navigation surgery in patients
with NSCLC. ICG fluorescence image-guided surgery has
been performed in patients with gastric,8 breast,9 and
skin10 cancers. ICG is widely used in a variety of examina-
tions, such as hepatic function tests,11 and applied to sentinel
node detection.12 However, because ICG is not visible in
anthracotic lymph nodes, the ICG dye-guided system was
not applied to lung surgery. On the other hand, although
the ICG fluorescence imaging system can improve this dis-
advantage, there have been no reports on ICG fluorescence
image-guided surgery for lung cancer or the use of video-The Journal of Thoracic and Caassisted thoracoscopic surgery with this imaging system.
The thoracoscopic ICG imaging system in this study was
useful for video-assisted thoracoscopic surgery with sentinel
node navigation surgery for lung cancer; 80.7% of our iden-
tification rate was similar to that obtained by radioactive
tracer injection. The Cancer and Leukemia Group B
140203 trial7 showed an unexpected low identification rate
of 51.2% for several reasons, such as technical failure, aero-
solization of radioactivity, and shine-through effect. Our
technique improved the outcome despite these limitations,
especially in hilar-located tumors, because there was no
shine-through effect and feasible results were obtained. An-
other benefit of this technique is less radioactivity for both
patient and surgeon. The sentinel nodes of 3 patients were
not identified by segmentectomy or lobectomy because the
ICG leaked from the injection site and eliminated specific vi-
sualization from the background; the injection sites were
closed with an EndoClip or Endoloop. Although the previous
report about dye-guided methods in breast cancer showed
a learning curve,13 the failure of identification in our resultsrdiovascular Surgery c Volume 141, Number 1 143
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Drevealed the possibility of a learning curve because these fail-
ures were found at the beginning of this study. The other rea-
sons for missing sentinel nodes were the adhesion of pleura
(2 patients) and incomplete fissure of lobes (1 patient). The
deeply located sentinel nodes from the lung parenchyma or
mediastinal fat tissue were invisible. A study including a large
population sample may help explain these failures.
Systemic radical lymph node dissection after lobectomy
or segmentectomy and pathologic examination proved these
sentinel nodes to be accurate sentinel nodes (negative senti-
nel nodes with no positive nodes or positive sentinel nodes
with mediastinal positive nodes). The fact that 24 of 31 pa-
tients had pathologically identified negative sentinel lymph
nodes may reflect the patient population. Many patients
had bronchioloalveolar carcinoma (48%), which is known
to show less frequent nodal metastasis. If the positive senti-
nel node was found by frozen-section analysis or real-time
reverse transcriptase-polymerase chain reaction using CK-
19 (data not shown) in segmentectomy during the operation,
the algorithm of the operation method was conversion from
segmentectomy to lobectomy, similar to that described in
a previous report.14 However, we found no positive
sentinel nodes in segmentectomy, and conversion was un-
necessary. A larger number of patients in a further study
may lead to more accurate results.CONCLUSIONS
Our study demonstrated that video-assisted thoracoscopic
ICG fluorescence image-guided surgery may be a powerful
tool to accurately detect the first basin of lymph drainage and
to eliminate unnecessary lymph node dissection in patients
with lung cancer.144 The Journal of Thoracic and Cardiovascular SurgReferences
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